The pathogenesis of rheumatoid arthritis

S Alivernini, GS Firestein, IB McInnes - Immunity, 2022 - cell.com
Significant recent progress in understanding rheumatoid arthritis (RA) pathogenesis has led
to improved treatment and quality of life. The introduction of targeted-biologic and-synthetic …

Pathogenetic insights from the treatment of rheumatoid arthritis

IB McInnes, G Schett - The Lancet, 2017 - thelancet.com
Rheumatoid arthritis is a chronic autoimmune disease that causes progressive articular
damage, functional loss, and comorbidity. The development of effective biologics and small …

Cytokines in rheumatoid arthritis—shaping the immunological landscape

IB McInnes, CD Buckley, JD Isaacs - Nature Reviews Rheumatology, 2016 - nature.com
Cytokine-mediated pathways are central to the pathogenesis of rheumatoid arthritis (RA).
The purpose of this short Opinion article is to briefly overview the roles of cytokine families in …

Systematic review: predicting and optimising response to anti‐TNF therapy in Crohn's disease–algorithm for practical management

NS Ding, A Hart, P De Cruz - Alimentary pharmacology & …, 2016 - Wiley Online Library
Background Nonresponse and loss of response to anti‐TNF therapies in Crohn's disease
represent significant clinical problems for which clear management guidelines are lacking …

The interplay between inflammation and metabolism in rheumatoid arthritis

MS Chimenti, P Triggianese, P Conigliaro… - Cell death & …, 2015 - nature.com
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by extensive
synovitis resulting in erosions of articular cartilage and marginal bone that lead to joint …

Metabolomics in rheumatoid arthritis: Advances and review

L Xu, C Chang, P Jiang, K Wei, R Zhang, Y Jin… - Frontiers in …, 2022 - frontiersin.org
Rheumatoid arthritis (RA) is an autoimmune disease accompanied by metabolic alterations.
The metabolic profiles of patients with RA can be determined using targeted and non …

Serum metabolomics identifies dysregulated pathways and potential metabolic biomarkers for hyperuricemia and gout

X Shen, C Wang, N Liang, Z Liu, X Li… - Arthritis & …, 2021 - Wiley Online Library
Objective To systematically profile metabolic alterations and dysregulated metabolic
pathways in hyperuricemia and gout, and to identify potential metabolite biomarkers to …

Pharmacometabonomics: data processing and statistical analysis

J Fu, Y Zhang, J Liu, X Lian, J Tang… - Briefings in …, 2021 - academic.oup.com
Individual variations in drug efficacy, side effects and adverse drug reactions are still
challenging that cannot be ignored in drug research and development. The aim of …

Mitochondria as key players in the pathogenesis and treatment of rheumatoid arthritis

SA Clayton, L MacDonald… - Frontiers in …, 2021 - frontiersin.org
Mitochondria are major energy-producing organelles that have central roles in cellular
metabolism. They also act as important signalling hubs, and their dynamic regulation in …

Metabolomics in rheumatic diseases: desperately seeking biomarkers

M Guma, S Tiziani, GS Firestein - Nature Reviews Rheumatology, 2016 - nature.com
Metabolomics enables the profiling of large numbers of small molecules in cells, tissues and
biological fluids. These molecules, which include amino acids, carbohydrates, lipids …